Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3310-3321

  Chiou, C C ^a   Mavrogiorgos, N ^a   Tillem, E ^a   Hector, R ^a   Walsh, T J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MICAFUNGIN; NIKKOMYCIN Z;

ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; ELECTRON MICROSCOPY; FUNGUS HYPHAE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; ULTRASTRUCTURE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLUS FUMIGATUS; DRUG SYNERGISM; KINETICS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; PEPTIDES, CYCLIC; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0035185523     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3310-3321.2001     Document Type: Article

References (18)

1. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer
2. Therapeutic outcome in invasive aspergillosis
3. Formation of a new cell wall by protoplasts of Candida albicans: Effect of papulacandin B, tunicamycin and Nikkomycin
4. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi
5. Characterization of the chitin biosynthesis process as a compensatory mechanism in the fks1 mutant of Saccharomyces cerevisiae
6. Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development
7. Compounds active against cell walls of medically important fungi
8. Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans
9. Efficacy of FK 463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
10. Antimicrobial susceptibility testing
11. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase
12. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT
13. Efficacy of FK 463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis
14. Synergistic interaction of nikkomycin and cilofungin against diverse fungi
15. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens
16. In vitro activities of new lipopeptide antifungal agent, FK 463, against a variety of clinically important fungi
17. Kinetics of nikkomycin Z degradation in aqueous solution and in plasma